07 June 2020
Visiongain has launched a new pharma report Dermatology Devices Market Report 2020-2030: Forecasts by Product (Diagnostic Devices (Biopsy Devices, Dermatoscopes, Microscopes, Other Imaging Devices), Treatment Devices (Cryotherapy Devices, Electrosurgical Equipment, Lasers, Light Therapy Devices, Liposuction Devices, Microdermabrasion Devices)), Application (Diagnostic Devices (Skin Cancer Diagnosis, Other), Treatment Devices (Acne, Psoriasis, and Tattoo Removal, Body Contouring and Fat Removal, Cellulite Reduction, Hair Removal, Skin Rejuvenation, Vascular and Pigmented Lesion Removal, Vascular and Pigmented Lesion Removal, Others)), End User (Clinics, Hospitals, Others), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).
The global dermatology devices market is anticipated to grow at a lucrative CAGR of xyz% and anticipated to reach USD xyz billion by 2020 owing to the growing prevalence of skin cancer and other skin diseases.
The prevalence of melanoma and non-melanoma skin cancers is increasing significantly. As per the reports of the Skin Cancer Foundation, the number of new melanoma cases diagnosed in 2020 will increase by almost 2 percent and an estimated 196,060 cases of melanoma will be diagnosed alone in the United States. The growing number of cases are anticipated to fuel market growth for dermatology devices over the forecast period.
The technological advancements in dermatology supported by FDA approvals and the development of novel therapies and devices to manage metastatic melanoma and malignant types of skin cancer, among others, are anticipated to fuel market growth over the forecast period. Also, the introduction of digitization within dermatological devices used for the accurate diagnosis will allow higher rates of adoption for these devices in developed economies. However, the strict regulatory landscape may hinder the growth of industry dermatological devices during the timeframe of the analysis.
In the year 2019, North America dominated the global dermatology devices market owing to the growing prevalence of skin cancer and other skin diseases such as eczema and rosacea and rising adoption of cosmetic dermatology procedures. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to growing beauty consciousness among the people across markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the dermatology devices market growth over the forecast period.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global dermatology devices market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the global market.
For instance, in April 2019 Alma Lasers announced the global launch of BeautiFill, the first laser-assisted fat harvesting platform on the market, designed to produce high-quality autologous fat for holistic body and face contouring, with the added benefits of reducing surgical procedure time and associated risks.
The comprehensive market report features companies such as 3Gen, Aesthetic Group., Alma Lasers, Ambicare Health., Bruker Corporation, Canfield Scientific, Inc., Carl Zeiss, Cutera, Cynosure, Inc., Genesis Biosystems, Inc., Heine Optotechnik GmbH & Co. Kg, Image Derm, Inc., Lumenis, Ltd., Michelson Diagnostics, Ltd., Photomedex, Inc., Solta Medical, Inc., Syneron, Valeant Pharmaceuticals International, Inc., among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.
15 June 2022
The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.